SPC
ETON icon

Sigma Planning Corp’s Eton Pharmaceutcials ETON Stock Holding History

Sigma Planning Corp’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
+30,000
New +$880K 0.03% 568

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Sigma Planning Corp's ETON Position: Q2 2026 in Review

Sigma Planning Corp opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 30,000 shares worth $1.09M. The stake represents 0.03% of the portfolio and ranks #568 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Sigma Planning Corp held 30,000 shares of Eton Pharmaceutcials worth $1.09M as of Q2 2026.
  • Eton Pharmaceutcials was a new Sigma Planning Corp position in Q2 2026.
  • Eton Pharmaceutcials made up 0.03% of Sigma Planning Corp's portfolio in Q2 2026, its #568 holding.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.